menu
    • menu
    [{"orgOrder":0,"company":"GCS Ramsay Sant\u00e9","sponsor":"Euraxi Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"FRANCE","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Hyaluronic Acid","moa":"Collagen synthesis","graph1":"Urology","graph2":"Undisclosed","graph3":"GCS Ramsay Sant\u00e9","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Injection","sponsorNew":"GCS Ramsay Sant\u00e9 \/ Euraxi Pharma","highestDevelopmentStatusID":"1","companyTruncated":"GCS Ramsay Sant\u00e9 \/ Euraxi Pharma"},{"orgOrder":0,"company":"Petrovax","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"RUSSIA","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Bovhyaluronidase Azoximer","moa":"Hyaluronidase","graph1":"Urology","graph2":"Undisclosed","graph3":"Petrovax","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Suppository","sponsorNew":"Petrovax \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Petrovax \/ Undisclosed"},{"orgOrder":0,"company":"Vensica Therapeutics","sponsor":"Blueclinical","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"ISRAEL","productType":"Protein","year":"2024","type":"Inapplicable","leadProduct":"Xeomin","moa":"SNAP25","graph1":"Urology","graph2":"Undisclosed","graph3":"Vensica Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Liquid, Instillation","sponsorNew":"Vensica Therapeutics \/ Blueclinical","highestDevelopmentStatusID":"1","companyTruncated":"Vensica Therapeutics \/ Blueclinical"},{"orgOrder":0,"company":"Vedic Lifesciences","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"INDIA","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Fucoidan Extracted","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"Vedic Lifesciences","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Vedic Lifesciences \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Vedic Lifesciences \/ Undisclosed"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"SOUTH KOREA","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Banana Flower Stamens Extract","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Sachet","sponsorNew":"TCI Co., Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"Se-cure Pharmaceuticals","sponsor":"Clalit","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"ISRAEL","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Brizo","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"Se-cure Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Se-cure Pharmaceuticals \/ Clalit","highestDevelopmentStatusID":"1","companyTruncated":"Se-cure Pharmaceuticals \/ Clalit"},{"orgOrder":0,"company":"Graminex","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Graminex G63 Flower Pollen Extract","moa":"||Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"Graminex","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Graminex \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Graminex \/ Undisclosed"},{"orgOrder":0,"company":"FEMPHARMA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"HUNGARY","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Incoxil Food Supplement","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"FEMPHARMA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"FEMPHARMA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"FEMPHARMA \/ Undisclosed"},{"orgOrder":0,"company":"Neopharm Bulgaria Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"BULGARIA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2024","type":"Inapplicable","leadProduct":"Neorenal Forte","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"Neopharm Bulgaria Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Neopharm Bulgaria Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Neopharm Bulgaria Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"The Bird and Be Co Inc","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"U.S.A","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Power Prenatal For Sperm","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"The Bird and Be Co Inc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"The Bird and Be Co Inc \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"The Bird and Be Co Inc \/ Undisclosed"},{"orgOrder":0,"company":"The Bird and Be Co Inc","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"U.S.A","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Power Prenatal For Sperm","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"The Bird and Be Co Inc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"The Bird and Be Co Inc \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"The Bird and Be Co Inc \/ Undisclosed"},{"orgOrder":0,"company":"Acrobio Healthcare Inc.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"TAIWAN","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"Prosta-Ok","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"Acrobio Healthcare Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Acrobio Healthcare Inc. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Acrobio Healthcare Inc. \/ Undisclosed"},{"orgOrder":0,"company":"Optimale","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Prostathrive Supplement","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"Optimale","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Optimale \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Optimale \/ Citruslabs"},{"orgOrder":0,"company":"Boston Scientific","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"U.S.A","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"Boston Scientific","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Boston Scientific \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Boston Scientific \/ Undisclosed"}]

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Neopharm Bulgaria Ltd.

                            Country arrow
                            BioJapan
                            Not Confirmed

                            Neopharm Bulgaria Ltd.

                            Country arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Neorenal Forte

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments

                            Details : Neorenal Forte is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Urolithiasis.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            October 21, 2024

                            Lead Product(s) : Neorenal Forte

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Petrovax

                            Russia arrow
                            BioJapan
                            Not Confirmed

                            Petrovax

                            Russia arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Bovhyaluronidase Azoximer

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prost...

                            Details : Bovhyaluronidase Azoximer is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Lower Urinary Tract Symptoms.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            August 23, 2024

                            Lead Product(s) : Bovhyaluronidase Azoximer

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Optimale

                            Country arrow
                            BioJapan
                            Not Confirmed

                            Optimale

                            Country arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Prostathrive Supplement

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Citruslabs

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tr...

                            Details : Prostathrive Supplement is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Lower Urinary Tract Symptoms.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 16, 2024

                            Lead Product(s) : Prostathrive Supplement

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Citruslabs

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Vedic Lifesciences

                            India arrow
                            BioJapan
                            Not Confirmed

                            Vedic Lifesciences

                            India arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fucoidan Extracted

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study to Assess the Effect of Fucoidan on Prostate Health in Males With Benign Prostatic Hyperplasia

                            Details : Fucoidan Extracted is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Prostatic Hyperplasia.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            July 05, 2024

                            Lead Product(s) : Fucoidan Extracted

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Vensica Therapeutics

                            Israel arrow
                            BioJapan
                            Not Confirmed

                            Vensica Therapeutics

                            Israel arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Xeomin

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Blueclinical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female ...

                            Details : Xeomin is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Urinary Bladder, Overactive.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            April 03, 2024

                            Lead Product(s) : Xeomin

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Blueclinical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            The Bird and Be Co Inc

                            Country arrow
                            BioJapan
                            Not Confirmed

                            The Bird and Be Co Inc

                            Country arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Power Prenatal For Sperm

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Prospective Study on Power Prenatal Vitamins for Males on YO Score At-home Sperm Test Results

                            Details : Power Prenatal For Sperm is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Spermatogenesis Disorders.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 18, 2023

                            Lead Product(s) : Power Prenatal For Sperm

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            GCS Ramsay Santé

                            Country arrow
                            BioJapan
                            Not Confirmed

                            GCS Ramsay Santé

                            Country arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Hyaluronic Acid

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Euraxi Pharma

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Hyaluronic Acid Injections on Functional Recovery After Surgery for Prostate Adenoma

                            Details : Ialuril (Hyaluronic Acid) is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Prostatic Hyperplasia.

                            Product Name : Ialuril

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            January 17, 2023

                            Lead Product(s) : Hyaluronic Acid

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Euraxi Pharma

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Graminex

                            U.S.A arrow
                            BioJapan
                            Not Confirmed

                            Graminex

                            U.S.A arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Graminex G63 Flower Pollen Extract,Norwegian Beta 1,3/1,6 Glucan

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Graminex, L.L.C. Completes Clinical Trial with Graminex Flower Pollen Extract Focusing on Women’s Urinary In...

                            Details : Preliminary analysis indicated significant improvements were found in the Graminex® Flower Pollen Extract study group for multiple urinary incontinence quality of life indicators.

                            Product Name : Pollimmune

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            August 01, 2022

                            Lead Product(s) : Graminex G63 Flower Pollen Extract,Norwegian Beta 1,3/1,6 Glucan

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            The Bird and Be Co Inc

                            Country arrow
                            BioJapan
                            Not Confirmed

                            The Bird and Be Co Inc

                            Country arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Power Prenatal For Sperm

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Power Prenatal Supplements for Sperm Quality

                            Details : Power Prenatal For Sperm is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Spermatogenesis Disorders.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            June 08, 2022

                            Lead Product(s) : Power Prenatal For Sperm

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            FEMPHARMA

                            Hungary arrow
                            BioJapan
                            Not Confirmed

                            FEMPHARMA

                            Hungary arrow
                            BioJapan
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Incoxil Food Supplement

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study of Incoxil Food Supplement in Female Patients With Stress Dominant Urinary Incontinence.

                            Details : Incoxil Food Supplement is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Urinary Incontinence.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            May 03, 2022

                            Lead Product(s) : Incoxil Food Supplement

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth